CF
EXAS

Corebridge Financial’s Exact Sciences EXAS Stock Holding History

Corebridge Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,022
Closed -$87.5K – 930
2025
Q1 		$87.5K Sell
2,022
-74
-4% -$3.75K ﹤0.01% 2509
2024
Q4 		$118K Sell
2,096
-110
-5% -$6.84K ﹤0.01% 2477
2024
Q3 		$150K Sell
2,206
-75
-3% -$4.23K ﹤0.01% 2383
2024
Q2 		$96.4K Buy
+2,281
New +$126K ﹤0.01% 2622

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Corebridge Financial's EXAS Position: Q2 2025 in Review

Corebridge Financial sold out of Exact Sciences (EXAS) in Q2 2025, closing a stake of 2,022 shares — an estimated $87.5K sold.

Corebridge Financial first reported a position in EXAS in Q2 2024 and held it in 4 quarters. The position peaked at $150K in Q3 2024. 559 funds tracked by Wall St. Rank hold EXAS as of Q2 2025.

  • Corebridge Financial reported no remaining Exact Sciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 2,022 Exact Sciences shares in Q2 2025, an estimated $87.5K.
  • Corebridge Financial first reported a position in Exact Sciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Exact Sciences position peaked at $150K in Q3 2024.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.